Reducing Home Labs for Pediatric Patients With Solid Tumors: Impact of a Novel Clinical Practice Guideline on Safety, Cost, and Quality of Life
ABSTRACT Introduction For pediatric patients with solid tumors, the use of growth factors following chemotherapy evolved from daily filgrastim to pegylated filgrastim. Currently, post‐chemotherapy laboratory work is obtained to monitor for transfusion needs rather than count recovery. We implemented...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2025-10-01
|
| Colección: | Cancer Medicine |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1002/cam4.71269 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|